Nonhuman primate models of social behavior and cocaine abuse

被引:39
|
作者
Nader, Michael A. [1 ]
Czoty, Paul W. [1 ]
Nader, Susan H. [1 ]
Morgan, Drake [2 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[2] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA
关键词
Aggression; Submission; Social interactions; Social consequences; Social rank; Cocaine self-administration; Nonhuman primates; MONKEYS MACACA-FASCICULARIS; DOPAMINE D2 RECEPTORS; CYNOMOLGUS MONKEYS; D-AMPHETAMINE; SQUIRREL-MONKEYS; RHESUS-MONKEYS; ENVIRONMENTAL ENRICHMENT; SOCIOECONOMIC-STATUS; CAGE SIZE; AFFILIATIVE BEHAVIOR;
D O I
10.1007/s00213-012-2843-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although cocaine is often abused in social situations, very few animal studies examine the effects of cocaine in the context of social behavior. This review highlights studies investigating the behavioral effects of cocaine in the context of social housing conditions using nonhuman primates. In addition, this review presents recent findings examining the effects of self-administering cocaine on social behavior and the effects of manipulations hypothesized to be stressful or enriching on the interactions between cocaine reinforcement and social rank. The following dependent variables are examined: (1) cocaine-induced changes in social behavior and (2) cocaine self-administration in cynomolgus monkeys of varying social ranks. The independent variables examined include several environmental and pharmacological manipulations. The studies reviewed here indicate that several variables can differentially affect cocaine self-administration when studied in a social context, rather than in individually housed animals. These variables include the social rank and sex of the individual, drug history, the nature of the "fear"-inducing manipulation, and the reliability of cortisol as an appropriate measure of "stress." While the inclusion of socially housed animals necessitates larger sample sizes, animal models incorporating social behavior are more homologous to the human condition and should be implemented when possible.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 50 条
  • [1] Nonhuman primate models of social behavior and cocaine abuse
    Michael A. Nader
    Paul W. Czoty
    Susan H. Nader
    Drake Morgan
    Psychopharmacology, 2012, 224 : 57 - 67
  • [2] Social Stress and Vulnerability to Cocaine Abuse in Nonhuman Primate Models
    Nader, Michael A.
    Czoty, Paul W.
    Riddick, Natallia V.
    Gould, Robert W.
    Gage, H. Donald
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 176S - 176S
  • [3] THE EFFECT OF NICOTINE ON COCAINE REINFORCEMENT IN A NONHUMAN PRIMATE MODEL OF COCAINE ABUSE
    Allen, Mia
    Johnson, Bernard
    Reboussin, Beth
    Nader, Michael
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [4] Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging
    Nader, Michael A.
    Banks, Matthew L.
    NEUROPHARMACOLOGY, 2014, 76 : 510 - 517
  • [5] Nonhuman primate models of drug abuse and AIDS
    Taffe, Michael A.
    Fox, Howard S.
    JOURNAL OF NEUROVIROLOGY, 2007, 13 : 13 - 13
  • [6] PET studies in nonhuman primate models of cocaine abuse: Translational research related to vulnerability and neuroadaptations
    Gould, Robert W.
    Duke, Angela N.
    Nader, Michael A.
    NEUROPHARMACOLOGY, 2014, 84 : 138 - 151
  • [7] Triggers of relapse: Nonhuman primate models of reinstated cocaine seeking
    Spealman, RD
    Lee, B
    Tiefenbacher, S
    Platt, DM
    Rowlett, JK
    Khroyan, TV
    MOTIVATIONAL FACTORS IN THE ETIOLOGY OF DRUG ABUSE, 2004, 50 : 57 - 84
  • [8] Effects of selective dopamine D3 receptor compounds in nonhuman primate models of cocaine and methamphetamine abuse
    John, William
    Green, Heather
    Newman, Amy
    Nader, Michael
    FASEB JOURNAL, 2014, 28 (01):
  • [9] THE EVOLUTION OF NONHUMAN PRIMATE SOCIAL-BEHAVIOR
    BERNSTEIN, IS
    GENETICA, 1987, 73 (1-2) : 99 - 116
  • [10] Nonhuman primate social colony models for screening antipsychotics
    Schlemmer, RF
    Young, JE
    Davis, JM
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 510 - 510